MediWound to Report Second Quarter 2025 Financial Results
MediWound (Nasdaq: MDWD), a leader in enzymatic therapeutics for tissue repair, will release its Q2 2025 financial results on Thursday, August 14, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and provide corporate updates.
Investors can access the call via multiple channels including toll-free numbers for US and Israel, and an international dial-in. A webcast replay will be available in the Investors section of MediWound's website after the call.
MediWound (Nasdaq: MDWD), leader nelle terapie enzimatiche per la riparazione dei tessuti, pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 驳颈辞惫别诲矛 14 agosto 2025. L'azienda terr脿 una conference call e una trasmissione in webcast alle 8:30 AM ora orientale per discutere i risultati e fornire aggiornamenti aziendali.
Gli investitori potranno partecipare alla chiamata tramite diversi canali, inclusi numeri verdi per USA e Israele, oltre a un numero internazionale. Una registrazione del webcast sar脿 disponibile nella sezione Investitori del sito web di MediWound dopo la chiamata.
MediWound (Nasdaq: MDWD), l铆der en terapias enzim谩ticas para la reparaci贸n de tejidos, publicar谩 sus resultados financieros del segundo trimestre de 2025 el jueves 14 de agosto de 2025. La compa帽铆a realizar谩 una conferencia telef贸nica y una transmisi贸n por webcast a las 8:30 a.m. hora del este para discutir los resultados y brindar actualizaciones corporativas.
Los inversores podr谩n acceder a la llamada a trav茅s de m煤ltiples canales, incluidos n煤meros gratuitos para EE. UU. e Israel, y una llamada internacional. Una repetici贸n del webcast estar谩 disponible en la secci贸n de Inversores del sitio web de MediWound despu茅s de la llamada.
MediWound (雮橃姢雼�: MDWD)電� 臁办 鞛儩鞚� 鞙勴暅 須唽 旃橂 攵勳暭鞚� 靹犽憪欤检瀽搿�, 2025雲� 2攵勱赴 鞛 瓴瓣臣毳� 2025雲� 8鞗� 14鞚� 氇╈殧鞚�鞐� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 瓴瓣臣毳� 雲检潣頃橁碃 旮办梾 鞐呺嵃鞚错姼毳� 鞝滉车頃橁赴 鞙勴暣 霃欕秬 響滌鞁� 鞓れ爠 8鞁� 30攵�鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃╇媹雼�.
韴瀽鞛愲摛鞚� 氙戈淡瓿� 鞚挫姢霛检棙鞚� 氍措 鞝勴檾氩堩樃 氚� 甑牅 鞝勴檾氩堩樃毳� 韽暔頃� 鞐煬 瓴诫毳� 韱淀暣 旖滌棎 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 旖� 鞚错泟 MediWound 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴鞐愳劀 鞗轨簮鞀ろ姼 鞛癌靻§潉 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
MediWound (Nasdaq : MDWD), leader dans les th茅rapeutiques enzymatiques pour la r茅paration des tissus, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 le jeudi 14 ao没t 2025. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une diffusion en webcast 脿 8h30, heure de l'Est pour discuter des r茅sultats et fournir des mises 脿 jour d'entreprise.
Les investisseurs pourront acc茅der 脿 l'appel via plusieurs canaux, y compris des num茅ros sans frais pour les 脡tats-Unis et Isra毛l, ainsi qu'un num茅ro d'appel international. Une rediffusion du webcast sera disponible dans la section Investisseurs du site web de MediWound apr猫s l'appel.
MediWound (Nasdaq: MDWD), ein f眉hrendes Unternehmen im Bereich enzymatischer Therapeutika zur Gewebereparatur, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 am Donnerstag, den 14. August 2025 ver枚ffentlichen. Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse zu besprechen und Unternehmensupdates zu geben.
Investoren k枚nnen 眉ber verschiedene Kan盲le an dem Anruf teilnehmen, darunter geb眉hrenfreie Nummern f眉r die USA und Israel sowie eine internationale Einwahlnummer. Eine Aufzeichnung des Webcasts wird nach der Telefonkonferenz im Investor-Bereich der MediWound-Website verf眉gbar sein.
- None.
- None.
MediWound to Report Second Quarter 2025 Financial Results
Conference call and webcast scheduled for Thursday, August 14 at 8:30 a.m. Eastern Time
YAVNE, Israel, August 4, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025.
Following the release, MediWound鈥檚 management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss these financial results and provide corporate updates.
Dial-in and call details are as follows:
Conference Call & Webcast Details
Toll-Free:聽 聽 聽 聽 聽 聽 聽 聽 1-844-676-8833
Israel:聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 1-80-9212373
International:聽 聽 聽 聽 聽1-412-634-6869
奥别产肠补蝉迟:听听听听听听听听听听听听听听听听
To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay on the Investors section of the MediWound website.
础产辞耻迟听惭别诲颈奥辞耻苍诲
MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair. The company鈥檚 FDA-approved biologic, NexoBrid庐, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the U.S., European Union, Japan, and other international markets. MediWound is also advancing EscharEx庐, a late-stage investigational therapy for the debridement of chronic wounds. EscharEx has demonstrated clinical advantages over the leading enzymatic debridement product and targets a substantial global market opportunity.
For more information visit and follow us on .
MediWound Contacts:听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听
Hani Luxenburg听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听Daniel Ferry
Chief Financial Officer聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽Managing Director
MediWound Ltd.聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽LifeSci Advisors, LLC
聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽听听听听听听听听
Media Contact:聽
Ellie Hanson
FINN Partners for MediWound
+1-929-588-2008
FAQ
When will MediWound (MDWD) report Q2 2025 earnings?
What time is MediWound's Q2 2025 earnings call?
How can I join MediWound's Q2 2025 earnings call?
Where can I find the replay of MediWound's Q2 2025 earnings call?
